Templeton AJ - Search Results

1

Metformin in chemotherapy-naive castration-resistant prostate cancer: a multicenter phase 2 trial (SAKK 08/09).

Rothermundt C, Hayoz S, Templeton AJ, Winterhalder R, Strebel RT, Bärtschi D, Pollak M, Lui L, Endt K, Schiess R, Rüschoff JH, Cathomas R, Gillessen S. Rothermundt C, et al. Among authors: templeton aj. Eur Urol. 2014 Sep;66(3):468-74. doi: 10.1016/j.eururo.2013.12.057. Epub 2014 Jan 4. Eur Urol. 2014. PMID: 24412228 Clinical Trial.

2

Remission of diabetes while on sunitinib treatment for renal cell carcinoma.

Templeton A, Brändle M, Cerny T, Gillessen S. Templeton A, et al. Ann Oncol. 2008 Apr;19(4):824-5. doi: 10.1093/annonc/mdn047. Epub 2008 Mar 6. Ann Oncol. 2008. PMID: 18326519 Free article. No abstract available.

3

Extraneural spread of glioblastoma--report of two cases.

Templeton A, Hofer S, Töpfer M, Sommacal A, Fretz C, Cerny T, Gillessen S. Templeton A, et al. Onkologie. 2008 Apr;31(4):192-4. doi: 10.1159/000118627. Epub 2008 Mar 20. Onkologie. 2008. PMID: 18418021

4

Concordant colon tumors in monozygotic twins previously treated for prostate cancer.

Templeton A, Marra G, Valtorta E, Heinimann K, Müller H, Köberle D, Gillessen S. Templeton A, et al. Fam Cancer. 2009;8(2):167-71. doi: 10.1007/s10689-008-9222-8. Epub 2008 Nov 16. Fam Cancer. 2009. PMID: 19011993 Free article.

5

Prostatic metastasis of renal cell carcinoma successfully treated with sunitinib.

Fokt RM, Templeton A, Gillessen S, Ohlschlegel C, Schmid HP. Fokt RM, et al. Urol Int. 2009;83(1):122-4. doi: 10.1159/000224882. Epub 2009 Jul 27. Urol Int. 2009. PMID: 19641373 Review.

6

Primary manifestation of small lymphocytic lymphoma in the prostate.

Fehr M, Templeton A, Cogliatti S, Aebersold F, Egli F, Gillessen S, Cathomas R. Fehr M, et al. Onkologie. 2009 Oct;32(10):586-8. doi: 10.1159/000232584. Epub 2009 Sep 11. Onkologie. 2009. PMID: 19816076 Review.

7

Risk of colorectal cancer in men on long-term androgen deprivation therapy for prostate cancer.

Gillessen S, Templeton A, Marra G, Kuo YF, Valtorta E, Shahinian VB. Gillessen S, et al. J Natl Cancer Inst. 2010 Dec 1;102(23):1760-70. doi: 10.1093/jnci/djq419. Epub 2010 Nov 10. J Natl Cancer Inst. 2010. PMID: 21068432 Free PMC article.

8

Cancer genetics-guided discovery of serum biomarker signatures for diagnosis and prognosis of prostate cancer.

Cima I, Schiess R, Wild P, Kaelin M, Schüffler P, Lange V, Picotti P, Ossola R, Templeton A, Schubert O, Fuchs T, Leippold T, Wyler S, Zehetner J, Jochum W, Buhmann J, Cerny T, Moch H, Gillessen S, Aebersold R, Krek W. Cima I, et al. Proc Natl Acad Sci U S A. 2011 Feb 22;108(8):3342-7. doi: 10.1073/pnas.1013699108. Epub 2011 Feb 7. Proc Natl Acad Sci U S A. 2011. PMID: 21300890 Free PMC article.

9

Novel prognostic markers in the serum of patients with castration-resistant prostate cancer derived from quantitative analysis of the pten conditional knockout mouse proteome.

Kälin M, Cima I, Schiess R, Fankhauser N, Powles T, Wild P, Templeton A, Cerny T, Aebersold R, Krek W, Gillessen S. Kälin M, et al. Eur Urol. 2011 Dec;60(6):1235-43. doi: 10.1016/j.eururo.2011.06.038. Epub 2011 Jun 29. Eur Urol. 2011. PMID: 21741162

10

Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08).

Templeton AJ, Dutoit V, Cathomas R, Rothermundt C, Bärtschi D, Dröge C, Gautschi O, Borner M, Fechter E, Stenner F, Winterhalder R, Müller B, Schiess R, Wild PJ, Rüschoff JH, Thalmann G, Dietrich PY, Aebersold R, Klingbiel D, Gillessen S; Swiss Group for Clinical Cancer Research (SAKK). Templeton AJ, et al. Eur Urol. 2013 Jul;64(1):150-8. doi: 10.1016/j.eururo.2013.03.040. Epub 2013 Apr 6. Eur Urol. 2013. PMID: 23582881 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

122 results

Search Page